Pure Global

Steady blood glucose test strips - Taiwan Registration 464fb388c8af4edf4c500567b39c97e7

Access comprehensive regulatory information for Steady blood glucose test strips in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 464fb388c8af4edf4c500567b39c97e7 and manufactured by LIFESCAN SCOTLAND LTD.;; LIFESCAN EUROPE GMBH. The authorized representative in Taiwan is DKSH TAIWAN LTD..

This page provides complete technical specifications, regulatory compliance details, 3 companies making similar products including LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTERNATIONAL;; LIFESCAN SCOTLAND LTD., LIFESCAN SCOTLAND LTD.;; LifeScan Europe GmbH, and 3 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
3 Competitors
3 Recent Registrations
464fb388c8af4edf4c500567b39c97e7
Registration Details
Taiwan FDA Registration: 464fb388c8af4edf4c500567b39c97e7
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Steady blood glucose test strips
TW: ็ฉฉ็ฟ่ก€็ณ–่ฉฆ็ด™
Risk Class 2

Registration Details

464fb388c8af4edf4c500567b39c97e7

DHA05602844606

Company Information

United Kingdom;;Switzerland

Product Details

This product is used with the OneTouch Select Plus series blood glucose monitoring system (OneTouch Select Plus, OneTouch Select Plus Flex) to quantitatively measure glucose (blood glucose) in fresh microvascular whole blood samples taken from fingertips. The blood glucose monitoring systems of the OneTouch Select Plus series are for a single patient only and should not be shared. The blood glucose monitoring systems of the OneTouch Select Plus series are not intended for the diagnosis or screening of diabetes, nor should they be used in newborns.

A Clinical chemistry and clinical toxicology

A.1345 Glucose Test System

Input;; Contract manufacturing

Dates and Status

Jun 20, 2016

Jun 20, 2026